{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:08:38Z","timestamp":1789427318073,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No. 2023J011809"],"award-info":[{"award-number":["No. 2023J011809"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]},{"name":"Zhangzhou Hospital Doctor Studio Climbing Project","award":["No. PDA202205"],"award-info":[{"award-number":["No. PDA202205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12026-024-09482-9","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T07:02:19Z","timestamp":1714460539000},"page":"766-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["FOXP4-AS1 promotes CD8+ T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1"],"prefix":"10.1007","volume":"72","author":[{"given":"Guo-yi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-zhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-zhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"9482_CR1","doi-asserted-by":"crossref","unstructured":"Sheikh M, et al. Current status and future prospects for esophageal cancer. Cancers. 2023;15(3):765.","DOI":"10.3390\/cancers15030765"},{"issue":"1","key":"9482_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20892\/j.issn.2095-3941.2016.0093","volume":"14","author":"H Liang","year":"2017","unstructured":"Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33\u201341.","journal-title":"Cancer Biol Med"},{"key":"9482_CR3","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.2147\/RMHP.S312790","volume":"14","author":"B Li","year":"2021","unstructured":"Li B, et al. Trends of esophageal cancer incidence and mortality and its influencing factors in China. Risk Manag Healthc Policy. 2021;14:4809\u201321.","journal-title":"Risk Manag Healthc Policy"},{"issue":"11","key":"9482_CR4","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","volume":"11","author":"S He","year":"2021","unstructured":"He S, et al. Advances and challenges in the treatment of esophageal cancer. Acta Pharm Sin B. 2021;11(11):3379\u201392.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"9482_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, et al. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15(5):1111\u201322.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"9482_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18(1):10.","journal-title":"Mol Cancer"},{"key":"9482_CR7","doi-asserted-by":"publisher","first-page":"1096717","DOI":"10.3389\/fonc.2022.1096717","volume":"12","author":"R Li","year":"2022","unstructured":"Li R, et al. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment. Front Oncol. 2022;12:1096717.","journal-title":"Front Oncol"},{"key":"9482_CR8","doi-asserted-by":"crossref","unstructured":"Vrana D, et al. From tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci. 2018;20(1):13.","DOI":"10.3390\/ijms20010013"},{"key":"9482_CR9","doi-asserted-by":"publisher","first-page":"1610140","DOI":"10.3389\/pore.2022.1610140","volume":"28","author":"C Yang","year":"2022","unstructured":"Yang C, Chen K. Long non-coding rna in esophageal cancer: a review of research progress. Pathol Oncol Res. 2022;28:1610140.","journal-title":"Pathol Oncol Res"},{"key":"9482_CR10","doi-asserted-by":"publisher","first-page":"799265","DOI":"10.3389\/fonc.2022.799265","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, et al. FOXP4-AS1 may be a potential prognostic biomarker in human cancers: a meta-analysis and bioinformatics analysis. Front Oncol. 2022;12:799265.","journal-title":"Front Oncol"},{"key":"9482_CR11","doi-asserted-by":"publisher","first-page":"773864","DOI":"10.3389\/fonc.2021.773864","volume":"11","author":"Y Niu","year":"2021","unstructured":"Niu Y, et al. LncRNA FOXP4-AS1 promotes the progression of esophageal squamous cell carcinoma by interacting with MLL2\/H3K4me3 to upregulate FOXP4. Front Oncol. 2021;11:773864.","journal-title":"Front Oncol"},{"issue":"7","key":"9482_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/cbin.11338","volume":"44","author":"Y Li","year":"2020","unstructured":"Li Y, et al. YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells. Cell Biol Int. 2020;44(7):1447\u201357.","journal-title":"Cell Biol Int"},{"issue":"1","key":"9482_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri3111","volume":"12","author":"X Jiang","year":"2011","unstructured":"Jiang X, Chen ZJ. The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol. 2011;12(1):35\u201348.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9482_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, et al. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"9482_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.","journal-title":"Mol Cancer"},{"issue":"2","key":"9482_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41418-022-01104-x","volume":"30","author":"YF Cao","year":"2023","unstructured":"Cao YF, et al. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. Cell Death Differ. 2023;30(2):527\u201343.","journal-title":"Cell Death Differ"},{"key":"9482_CR17","doi-asserted-by":"crossref","unstructured":"Borgmann M, Quante M. Impact of the tumor microenvironment for esophageal tumor development-an opportunity for prevention?. Cancers. 2022;14(9):2246.","DOI":"10.3390\/cancers14092246"},{"issue":"1","key":"9482_CR18","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020;11(1):6268.","journal-title":"Nat Commun"},{"issue":"40","key":"9482_CR19","doi-asserted-by":"publisher","first-page":"e27473","DOI":"10.1097\/MD.0000000000027473","volume":"100","author":"C Liao","year":"2021","unstructured":"Liao C, et al. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma. Medicine. 2021;100(40):e27473.","journal-title":"Medicine"},{"issue":"3","key":"9482_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5483\/BMBRep.2019.52.3.048","volume":"52","author":"N Poondla","year":"2019","unstructured":"Poondla N, et al. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities? BMB Rep. 2019;52(3):181\u20139.","journal-title":"BMB Rep"},{"key":"9482_CR21","doi-asserted-by":"crossref","unstructured":"Tao L, et al. USP10 as a potential therapeutic target in human cancers. Genes. 2022;13(5):831.","DOI":"10.3390\/genes13050831"},{"key":"9482_CR22","doi-asserted-by":"publisher","first-page":"829705","DOI":"10.3389\/fonc.2022.829705","volume":"12","author":"D Gao","year":"2022","unstructured":"Gao D, et al. The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target. Front Oncol. 2022;12:829705.","journal-title":"Front Oncol"},{"issue":"1","key":"9482_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi A, et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun Signal. 2022;20(1):44.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"9482_CR24","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1159\/000480000","volume":"42","author":"L Chen","year":"2017","unstructured":"Chen L, et al. PD-L1 expression promotes epithelial to mesenchymal transition in human esophageal cancer. Cell Physiol Biochem. 2017;42(6):2267\u201380.","journal-title":"Cell Physiol Biochem"},{"issue":"17","key":"9482_CR25","doi-asserted-by":"publisher","first-page":"17062","DOI":"10.18632\/aging.103634","volume":"12","author":"J Xu","year":"2020","unstructured":"Xu J, et al. Evidence that dysplasia related microRNAs in Barrett\u2019s esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma. Aging. 2020;12(17):17062\u201378.","journal-title":"Aging"},{"issue":"1\u20132","key":"9482_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41434-022-00331-8","volume":"30","author":"H Wang","year":"2023","unstructured":"Wang H, et al. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3\/miR-21. Gene Ther. 2023;30(1\u20132):88\u2013100.","journal-title":"Gene Ther"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09482-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T02:08:34Z","timestamp":1724724514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09482-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["9482"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09482-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Ethics Committee of Zhangzhou Affiliated Hospital of Fujian Medical University (No. 2022KYB149).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}